Jenburkt Pharmaceuticals Limited (BOM:524731)

Jenburkt Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 15, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	4,859	3,043	2,939	2,601	1,828	1,459
Market Cap Growth	78.59%	3.52%	13.02%	42.23%	25.34%	-37.08%
Enterprise Value	4,103	2,488	2,474	2,149	1,172	945
Last Close Price	1100.90	677.38	642.09	533.82	367.78	293.42
PE Ratio	15.47	11.71	11.95	11.66	11.08	9.81
PS Ratio	3.25	2.14	2.15	2.10	1.67	1.23
PB Ratio	3.08	2.10	2.40	2.22	1.86	1.82
P/TBV Ratio	3.09	2.11	2.40	2.22	1.87	1.84
P/FCF Ratio	-	54.63	19.66	41.83	9.99	13.94
P/OCF Ratio	-	37.46	17.24	28.05	9.40	9.71
EV/Sales Ratio	2.74	1.75	1.81	1.73	1.07	0.80
EV/EBITDA Ratio	10.56	7.68	8.28	8.04	6.15	5.05
EV/EBIT Ratio	11.14	8.08	8.78	8.45	6.58	5.42
EV/FCF Ratio	-	44.68	16.55	34.56	6.40	9.04
Debt / Equity Ratio	0.01	-	0.02	0.06	0.05	0.07
Debt / EBITDA Ratio	0.05	-	0.10	0.25	0.26	0.27
Debt / FCF Ratio	-	-	0.20	1.09	0.28	0.50
Asset Turnover	-	0.93	0.96	0.94	0.97	1.15
Inventory Turnover	-	3.71	3.71	3.67	3.32	3.25
Quick Ratio	-	6.01	4.48	3.00	3.91	3.87
Current Ratio	-	6.70	5.15	3.57	4.45	4.52
Return on Equity (ROE)	-	19.43%	20.52%	20.66%	18.49%	18.89%
Return on Assets (ROA)	-	12.54%	12.37%	12.04%	9.87%	10.53%
Return on Capital (ROIC)	15.85%	14.24%	14.12%	13.97%	11.80%	12.82%
Return on Capital Employed (ROCE)	-	20.70%	22.40%	20.90%	17.30%	20.60%
Earnings Yield	6.46%	8.54%	8.37%	8.57%	9.03%	10.19%
FCF Yield	-	1.83%	5.08%	2.39%	10.01%	7.17%
Dividend Yield	1.39%	2.26%	2.24%	2.25%	2.77%	2.76%
Payout Ratio	-	24.32%	22.35%	20.99%	-	57.71%
Buyback Yield / Dilution	-3.09%	3.34%	0.52%	-	-	-
Total Shareholder Return	-1.68%	5.60%	2.76%	2.25%	2.77%	2.76%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.